These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32427692)

  • 1. The role of PPARα in autosomal dominant polycystic kidney disease.
    Lakhia R
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):432-438. PubMed ID: 32427692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.
    Lakhia R; Yheskel M; Flaten A; Quittner-Strom EB; Holland WL; Patel V
    Am J Physiol Renal Physiol; 2018 Jan; 314(1):F122-F131. PubMed ID: 28903946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.
    Hajarnis S; Lakhia R; Yheskel M; Williams D; Sorourian M; Liu X; Aboudehen K; Zhang S; Kersjes K; Galasso R; Li J; Kaimal V; Lockton S; Davis S; Flaten A; Johnson JA; Holland WL; Kusminski CM; Scherer PE; Harris PC; Trudel M; Wallace DP; Igarashi P; Lee EC; Androsavich JR; Patel V
    Nat Commun; 2017 Feb; 8():14395. PubMed ID: 28205547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
    Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
    Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).
    Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA
    FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
    Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
    J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
    Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
    Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating inflammation with interleukin 37 treatment ameliorates murine Autosomal Dominant Polycystic Kidney Disease.
    Zylberberg AK; Cottle DL; Runting J; Rodrigues G; Tham MS; Jones LK; Cumming HE; Short KM; Zaph C; Smyth IM
    Kidney Int; 2024 Apr; 105(4):731-743. PubMed ID: 38158181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.
    Lakhia R; Yheskel M; Flaten A; Ramalingam H; Aboudehen K; Ferrè S; Biggers L; Mishra A; Chaney C; Wallace DP; Carroll T; Igarashi P; Patel V
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32182218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease.
    Zhang JQJ; Saravanabavan S; Munt A; Wong ATY; Harris DC; Harris PC; Wang Y; Rangan GK
    Expert Rev Mol Med; 2019 Nov; 21():e6. PubMed ID: 31767049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
    Jansson K; Venugopal J; Sánchez G; Magenheimer BS; Reif GA; Wallace DP; Calvet JP; Blanco G
    J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
    Liu Y; Dai B; Fu L; Jia J; Mei C
    Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and mitochondria in polycystic kidney disease research and therapy.
    Padovano V; Podrini C; Boletta A; Caplan MJ
    Nat Rev Nephrol; 2018 Nov; 14(11):678-687. PubMed ID: 30120380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease.
    Ren Y; Zhu X; Fu K; Zhang H; Zhao W; Lin Y; Fang Q; Wang J; Chen Y; Guo D
    Biochem Pharmacol; 2023 Jan; 207():115355. PubMed ID: 36442624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.